// App-Quantinova.ai

1582 : Genotype concordance between archival tumor DNA (atDNA) and circulating tumor DNA (ctDNA) in advanced solid malignancies: The Oncopanel Pilot study.

Researchers

Presenter

  • Hagen F. Kennecke

Principal Investigators

  • Colleen E. McGahan

  • Solomon A. Vandt

  • Jonathan M. Loree

  • Ian Bosdet

  • Lucas Swanson

  • Liz Starks

  • Jordan Davidson

  • Christopher Tan

  • John Paul McGhie

  • Bal Johal

  • Sara Kristina Taylor

  • Muhammad Zulfiqar

  • Janessa J. Laskin

  • Janine Marie Davies

  • Barbara L. Melosky

  • Sophie Sun

  • Aly Karsan

  • Ryan Morin

Medical Centers

  • BC Cancer Agency, Vancouver, BC, Canada

  • Simon Fraser University, Vancouver, BC, Canada

  • British Columbia Cancer Agency, Cancer Surveillance & Outcomes, Vancouver, BC, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • University of Alberta, Vancouver, BC, Canada

  • Department of Pathology, BC Cancer Agency and University of British Columbia, Vancouver, BC, Canada

  • Centre for Clinical Genomics,British Columbia Genome Sciences Centre, BCCA, Vancouver, BC, Canada

  • Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • BC Cancer Agency, Kelowna, BC, Canada

  • British Columbia Cancer Agency, Abbotsford Centre, Vancouver, BC, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Melanoma

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Epidermal growth factor receptor

  • GTPase Nras

  • KRAS proto-oncogene, GTPase

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02171286

Sponsors

  • N/A

Result

  • Final